Yip CW - Search Results

1

Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance.

Kam KM, Sloutsky A, Yip CW, Bulled N, Seung KJ, Zignol M, Espinal M, Kim SJ. Kam KM, et al. Among authors: yip cw. Int J Tuberc Lung Dis. 2010 Mar;14(3):282-8. Int J Tuberc Lung Dis. 2010. PMID: 20132618

2

Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.

Kam KM, Yip CW. Kam KM, et al. Among authors: yip cw. Int J Tuberc Lung Dis. 2001 Sep;5(9):815-23. Int J Tuberc Lung Dis. 2001. PMID: 11573892

3

Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.

Kam KM, Yip CW. Kam KM, et al. Among authors: yip cw. Int J Tuberc Lung Dis. 2004 Jun;8(6):760-6. Int J Tuberc Lung Dis. 2004. PMID: 15182147

4

Denaturing HPLC for high-throughput screening of rifampicin-resistant Mycobacterium tuberculosis isolates.

Yip CW, Leung KL, Wong D, Cheung DT, Chu MY, Tang HS, Kam KM. Yip CW, et al. Int J Tuberc Lung Dis. 2006 Jun;10(6):625-30. Int J Tuberc Lung Dis. 2006. PMID: 16776449

5

Bulk acid-fast staining of sputum smears: time to end a taboo.

Kam KM, Yip CW, Tang HS, Van Deun A. Kam KM, et al. Among authors: yip cw. Int J Tuberc Lung Dis. 2009 Sep;13(9):1119-23. Int J Tuberc Lung Dis. 2009. PMID: 19723401

6

Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs.

Leung KL, Yip CW, Yeung YL, Wong KL, Chan WY, Chan MY, Kam KM. Leung KL, et al. Among authors: yip cw. J Appl Microbiol. 2010 Dec;109(6):2087-94. doi: 10.1111/j.1365-2672.2010.04840.x. Epub 2010 Sep 21. J Appl Microbiol. 2010. PMID: 20854453

7

Random blinded rechecking of sputum acid-fast bacilli smear using fluorescence microscopy: 8 years' experience.

Yip CW, Chan MY, Cheung WF, Yu KW, Tang HS, Kam KM. Yip CW, et al. Int J Tuberc Lung Dis. 2012;16(3):398-401. doi: 10.5588/ijtld.11.0330. Int J Tuberc Lung Dis. 2012. PMID: 22640454

8

A pilot external quality assurance programme for line-probe assay detection of anti-tuberculosis drug resistance.

Leung KL, Yip CW, Tang HS, Lai YW, Lam TK, Kam KM. Leung KL, et al. Among authors: yip cw. Int J Tuberc Lung Dis. 2013 Feb;17(2):262-6. doi: 10.5588/ijtld.12.0533. Epub 2012 Dec 14. Int J Tuberc Lung Dis. 2013. PMID: 23244351

9

Peak plasma rifampicin level in tuberculosis patients with slow culture conversion.

Chang KC, Leung CC, Yew WW, Kam KM, Yip CW, Ma CH, Tam CM, Leung EC, Law WS, Leung WM. Chang KC, et al. Among authors: yip cw. Eur J Clin Microbiol Infect Dis. 2008 Jun;27(6):467-72. doi: 10.1007/s10096-007-0454-6. Epub 2008 Jan 24. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18214560

10

Seventy percent of the Mycobacterium tuberculosis isolates in Hong Kong represent the Beijing genotype.

Chan MY, Borgdorff M, Yip CW, de Haas PE, Wong WS, Kam KM, Van Soolingen D. Chan MY, et al. Among authors: yip cw. Epidemiol Infect. 2001 Aug;127(1):169-71. doi: 10.1017/s0950268801005659. Epidemiol Infect. 2001. PMID: 11561969 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters